OpenBilldrug price receipt

NADAC week of 2026-10-14

GUANFACINE HCL ER 2 MG TABLET

For 30 tablets

Pharmacies pay

$4.43 filed

30 × $0.14767 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$25.20 filed

30 × $0.83991 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.7× estimated

Medicare paid 5.7× what pharmacies pay.

Part D averages every strength and form sold under “Guanfacine HCl ER” / “Guanfacine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$10.09 estimated

$4.43 + $0.66 (15%) + $5.00 fee per fill = $10.09

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

GUANFACINE HCL ER 2 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as guanfacine, under the trade name “Guanfacine Extended-Release”.

FDA gives its dosage form as tablet, extended release and its route as oral.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Upsher-Smith Laboratories, LLC and Unichem Pharmaceuticals (USA), Inc.

FDA’s Established Pharmacologic Class for it is Central alpha-2 Adrenergic Agonist.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.43 for 30 tablets (30 × $0.14767 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 8 labelers

LabelerNDCsPharmacies pay per unit
Actavis Pharma, Inc.1$0.14767 per EA filed
Advagen Pharma Limited1$0.14767 per EA filed
Alembic Pharmaceuticals Inc.1$0.14767 per EA filed
Apotex Corp.1$0.14767 per EA filed
Fosun Pharma USA, Inc1$0.14767 per EA filed
Slate Run Pharmaceuticals, LLC1$0.14767 per EA filed
Unichem Pharmaceuticals (USA), Inc.1$0.14767 per EA filed
Upsher-Smith Laboratories, LLC1$0.14767 per EA filed
All 8 NDCs, with labeler and price
  • 00228-2851-11 · Actavis Pharma, Inc. · $0.14767 per EA · eff. 2026-09-23 filed
  • 24979-0534-01 · Upsher-Smith Laboratories, LLC · $0.14767 per EA · eff. 2026-09-23 filed
  • 29300-0461-01 · Unichem Pharmaceuticals (USA), Inc. · $0.14767 per EA · eff. 2026-09-23 filed
  • 60505-3928-01 · Apotex Corp. · $0.14767 per EA · eff. 2026-09-23 filed
  • 62332-0746-31 · Alembic Pharmaceuticals Inc. · $0.14767 per EA · eff. 2026-09-23 filed
  • 70436-0040-01 · Slate Run Pharmaceuticals, LLC · $0.14767 per EA · eff. 2026-09-23 filed
  • 72266-0256-55 · Fosun Pharma USA, Inc · $0.14767 per EA · eff. 2026-09-23 filed
  • 72888-0225-01 · Advagen Pharma Limited · $0.14767 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

9 other products in the NADAC file share the FDA nonproprietary name guanfacine with GUANFACINE HCL ER 2 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
GUANFACINE 1 MG TABLET
generic · tablet
$0.14657 per EA filed
eff. 2026-09-23
$0.56698 per EA filed
Part D 2024 average
GUANFACINE 2 MG TABLET
generic · tablet
$0.26727 per EA filed
eff. 2026-09-23
$0.56698 per EA filed
Part D 2024 average
GUANFACINE HCL ER 1 MG TABLET
generic · tablet, extended release
$0.13256 per EA filed
eff. 2026-09-23
$0.83991 per EA filed
Part D 2024 average
GUANFACINE HCL ER 2 MG TABLET this page
generic · tablet, extended release
$0.14767 per EA filed
eff. 2026-09-23
$0.83991 per EA filed
Part D 2024 average
GUANFACINE HCL ER 3 MG TABLET
generic · tablet, extended release
$0.16584 per EA filed
eff. 2026-09-23
$0.83991 per EA filed
Part D 2024 average
GUANFACINE HCL ER 4 MG TABLET
generic · tablet, extended release
$0.17621 per EA filed
eff. 2026-09-23
$0.83991 per EA filed
Part D 2024 average
INTUNIV ER 1 MG TABLET
brand · tablet, extended release
$9.38648 per EA filed
eff. 2026-09-23
We don’t know yet
INTUNIV ER 2 MG TABLET
brand · tablet, extended release
$9.26199 per EA filed
eff. 2026-09-23
We don’t know yet
INTUNIV ER 3 MG TABLET
brand · tablet, extended release
$9.29231 per EA filed
eff. 2026-09-23
We don’t know yet
INTUNIV ER 4 MG TABLET
brand · tablet, extended release
$9.26984 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $0.14767 per EA filed.

Of the 22 other products in FDA’s Central alpha-2 Adrenergic Agonist class priced per EA, 12 have a higher middle NADAC price and 10 a lower one. The one in the middle is GUANFACINE HCL ER 3 MG TABLET, at $0.16584 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $25.20 for 30 tablets, at an average of $0.83991 per EA in 2024 (2024-01-01 to 2024-12-31) for “Guanfacine HCl ER” and “Guanfacine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 134,577 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for GUANFACINE HCL ER 2 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Guanfacine HCl ER / Guanfacine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.